MicroRNA in radiotherapy: miRage or miRador?
Elina Korpela(Sunnybrook Health Science Centre), Stanley K. Liu(University of Toronto)
Cited by 67
Related Papers
Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis
|British Journal of Cancer|2017|91
miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA
|Cancer Letters|2019|59
mi<scp>RNA</scp>‐106a and prostate cancer radioresistance: a novel role for <scp>LITAF</scp> in <scp>ATM</scp> regulation
|Molecular Oncology|2018|47
RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer
|Journal of Translational Medicine|2019|36
MicroRNA‑198 suppresses prostate tumorigenesis by targeting MIB1
|Oncology Reports|2019|23